The paaR2-paaA2-parE2 operon is a three-component toxin-antitoxin module encoded in the genome of the human pathogen Escherichia coli O157. The toxin (ParE2) and antitoxin (PaaA2) interact to form a nontoxic toxin-antitoxin complex. In this paper, the crystallization and preliminary characterization of two variants of the ParE2-PaaA2 toxin-antitoxin complex are described. Selenomethionine-derivative crystals of the full-length ParE2-PaaA2 toxinantitoxin complex diffracted to 2.8 Å resolution and belonged to space group P4 1 2 1 2 (or P4 3 2 1 2), with unit-cell parameters a = b = 90.5, c = 412.3 Å . It was previously reported that the full-length ParE2-PaaA2 toxin-antitoxin complex forms a higher-order oligomer. In contrast, ParE2 and PaaA2 13-63 , a truncated form of PaaA2 in which the first 12 N-terminal residues of the antitoxin have been deleted, form a heterodimer as shown by analytical gel filtration, dynamic light scattering and small-angle X-ray scattering. Crystals of the PaaA2 13-63 -ParE2 complex diffracted to 2.7 Å resolution and belonged to space group P6 1 22 (or P6 5 22), with unit-cell parameters a = b = 91.6, c = 185.6 Å .
Introduction
Toxin-antitoxin (TA) modules constitute a stress-response network that provides bacteria and archaea with tools enabling swift adaptation to ever-changing environments. These modules are widespread in the genomes of bacteria and archaea (Leplae et al., 2011; Blower et al., 2012) and have been linked to the adaptation of the metabolism of the cell under physiological stress (Christensen et al., 2003; Cooper et al., 2009; Christensen-Dalsgaard et al., 2010) , the generation of persister cells (Shah et al., 2006; Maisonneuve et al., 2011) , quorumsensing-induced and stress-induced programmed cell death (Sat et al., 2003; Hazan et al., 2004; Kolodkin-Gal et al., 2007) and the maintenance of unstable genetic elements carrying genes necessary for survival of a bacterium (Moritz & Hergenrother, 2007; Szekeres et al., 2007) . Typically, TA modules are two-gene operons comprising the open reading frame of the toxin preceded by the gene encoding the antitoxin, which can either be an mRNA or a protein molecule (Gerdes et al., 2005; Blower et al., 2011) . Although this constitutes the archetypal TA module, variations on this theme have been reported (Christensen-Dalsgaard & Gerdes, 2006; Hallez et al., 2010) . In type II TA modules, which are the most frequent, both the toxin and the antitoxin are proteins. TA toxins have the ability to completely shut down the metabolism of the cell by interacting with key components of the cellular machinery. Known targets for TA-encoded toxins are DNA gyrase (Bernard & Couturier, 1992; Jiang et al., 2002; Dao-Thi et al., 2005; Yuan et al., 2010) , elongation factor Ef-Tu , the ribosome (Vesper et al., 2011; Zhang & Inouye, 2011; Schifano et al., 2013) , mRNA Neubauer et al., 2009) , tRNA (Winther & Gerdes, 2011) , components for cell-wall synthesis (Mutschler et al., 2011) and glutamyl-tRNA synthetase GltX (Germain et al., 2013) . Luckily for the cell, the activity of the toxin can be countered by its cognate antitoxin (Pedersen et al., 2002; Zhang, Zhang, Hoeflich et al., 2003; Zhao & Zhang, 2008) . These activities are regulated via the antitoxin at the levels of both protein activity and transcription (for a review, see .
Type II TA toxins and antitoxins are categorized into toxin and antitoxin superfamilies, respectively. The toxin superfamilies are defined based on the three-dimensional structures of the toxins. To date, seven toxin superfamilies (MazF/CcdB, RelE/ParE, VapC, HipA, Doc, and HicA) have been identified. However, this number is expected to increase, as type II toxins unrelated to the mentioned superfamilies have been discovered through combined computational and experimental approaches (Florek et al., 2011; Leplae et al., 2011; Russell et al., 2011; Smith et al., 2011; Ren et al., 2012) . The diversity in antitoxin superfamilies exceeds that of the toxins as 20 antitoxin superfamilies have already been listed (Leplae et al., 2011) : Phd, RelB, PasA, MazE, HigA, VapX, CcdA, ", ParD and FizA-FizK. The archetypal type II antitoxins are dimers consisting of two domains with distinct functions. The N-terminal part is a DNA-binding domain (DBD), which varies from superfamily to superfamily. The C-terminal moiety serves as a toxin-binding domain and is intrinsically disordered in most antitoxins when not in complex with the toxin (Madl et al., 2006; Oberer et al., 2007; Garcia-Pino et al., 2010) . Upon binding of the antitoxin to its cognate toxin, this part wraps itself around the toxin, thereby adopting structure in a process called 'folding upon binding' (Kamada & Hanaoka, 2005; Garcia-Pino et al., 2008; De Jonge et al., 2009 ). However, the antitoxin superfamilies also contain atypical variants which harbour features that deviate from the aforementioned hallmarks. These antitoxins can be (i) dimers in which the roles of the termini have been inverted (Brown et al., 2009 ), (ii) dimers without DBDs (Meinhart et al., 2003) or (iii) monomers without DBDs (Takagi et al., 2005) .
As an additional variation on the type II TA modules, threecomponent systems have been described in which the antitoxin is split into a DNA-binding regulator and a non-DNA-binding antitoxin. The prophage region of the Escherichia coli O157 genome harbours two such three-component type II TA modules: paaR1-paaA1-parE1 and paaR2-paaA2-parE2 (Hallez et al., 2010) . The toxins, ParE1 and ParE2, are members of the RelE/ParE toxin superfamily. In vivo, expression of the parE genes leads to cell death by eliciting the SOS response, an event which can be countered by the respective antitoxins, PaaA1 and PaaA2 (Hallez et al., 2010) . These antitoxins are atypical members of the RelB antitoxin superfamily as they contain no DBD and exist as monomers in solution (Sterckx et al., 2014) . Transcriptional repression of both operons is mainly ensured by the respective regulators, PaaR1 and PaaR2, which are encoded upstream of the antitoxin and toxin genes and contain a DNAbinding domain of the DicA transcriptional repressor family. It is clear that PaaA2 and ParE2 physically interact with each other as previous reports have shown that the proteins co-purify and form a large oligomeric complex in solution, which was proposed to be a heterododecamer (Sterckx et al., 2012) . To date, it has not been shown that PaaR2 physically interacts with the ParE2-PaaA2 toxinantitoxin complex (Hallez et al., 2010) . Previously reported crystals of full-length ParE2-PaaA2 only diffracted to about 4 Å resolution and Coding regions of the used expression vectors. The ORFs of paaA2 and parE2 are highlighted by blue and red boxes, respectively. Grey boxes indicate purification tags and protease cleavage sites. The single nucleotide separating the paaA2 and parE2 ORFs is indicated in bold. The resulting amino-acid sequences are also shown in bold and the molecular masses of the produced proteins are indicated. did not allow structure determination (Sterckx et al., 2012) . In this paper, we report a new crystal form of the ParE2-PaaA2 toxinantitoxin complex. Furthermore, we also describe the crystallization and hydrodynamic characterization of the complex between ParE2 and PaaA2 13-63 , a PaaA2 truncation in which the first 12 N-terminal residues of the antitoxin have been deleted.
Material and methods
2.1. Cloning, protein production and purification Two expression vectors, pET21b-A2-E2His and pET21b-A2 13-63 -HisE2, were constructed and encode the full-length and truncated ParE2-PaaA2 complexes, respectively. pET21b-A2-E2His was obtained by extracting the paaA2-parE2 coding region (UniProtKB accession Q8XAD5 and Q8X366) from E. coli O157:H7 EDL933 as described by Hallez et al. (2010) and introducing it into the pET-21b vector (Novagen) via the EcoRI and XhoI sites using the primers 5 0 -GAATTCAGGAGGGAGTAATGGATTATAAAGATGACGATG-ACAAAAATAGAGCCCTTTCACCA-3 0 (forward) and 5 0 -CGCA-AGACGCCAGTTTCCCCTCGAG-3 0 (reverse). This construct provides PaaA2 with an N-terminal FLAG tag (DYKDDDDK) and ParE2 with a C-terminal His tag (LEHHHHHH). pET21b-A2 13-63 -HisE2 was created by modifying pET21b-A2-E2His through commercial cloning (GenScript). Briefly, the region encoding the FLAG tag and the first 12 native residues of PaaA2 were deleted, and the His tag of ParE2 was displaced from the C-terminus to the N-terminus and equipped with a thrombin cleavage site. The resulting vector thus carries a truncated version of PaaA2 (PaaA2 13-63 ) and equips ParE2 with an N-terminal His tag with a thrombin cleavage site (MGSSHHHHHHSSGLVPRGSH). Transformation of the expression vectors and protein production and purification were performed as described by Sterckx et al. (2012) . The progress of the purification was monitored by SDS-PAGE analysis. The samples were loaded onto a 15% acrylamide gel (30% acryl/bisacrylamide, 1.5 M Tris pH 8.0, 10% SDS, 10% APS, 1% TEMED). Electrophoresis was performed in 1Â Laemmli buffer (25 mM Tris pH 8.3, 192 mM glycine, 0.1% SDS) for 20 min at 180 V, 20 min at 190 V and 20 min at 200 V. Protein bands were visualized with Coomassie Brilliant Blue R250 and molecular masses were determined using the Prestained Protein Molecular Weight Marker (Fermentas). The amino-acid sequences of the proteins encoded by pET21b-A2-E2His and pET21b-A2 13-63 -HisE2 are shown in Fig. 1 .
In order to obtain an SeMet derivative of the full-length ParE2-PaaA2 complex, pET21b-A2-E2His was purified from E. coli strain BL21 (DE3) using a Qiagen Miniprep according to the manufacturer's instructions. The purified vector was transformed into the auxotrophic E. coli strain B834 (DE3) (Studier et al., 1990) using the CaCl 2 method (Hanahan et al., 1991) . Transformed cells were selected on LB plates containing 100 mg ml À1 ampicillin and 2%(w/v) glucose and were grown overnight at 310 K. A single colony was re-plated on a minimal medium plate supplemented with 100 mg ml À1 ampicillin, 0.2%(w/v) glucose and 50 mg ml À1 l-Met. Expression was first tested on a small scale in SeMet medium (Molecular Dimensions). An individual colony was picked to start an overnight 5 ml pre-culture incubated in SeMet medium supplemented with 100 mg ml À1 ampicillin, 0.2%(w/v) glucose and 50 mg ml À1 l-Met at 310 K with aeration. After overnight incubation, the cells were pelleted and washed three times with 5 ml sterile water before being resuspended in 1 ml sterile water. A main culture was then started by inoculating an Erlenmeyer flask containing 50 ml pre-warmed (310 K) SeMet medium supplemented with 100 mg ml À1 ampicillin, 0.2%(w/v) glucose and 50 mg ml À1 l-SeMet with the 1 ml pre-culture. Expression of the genes was induced by the addition of 1 mM IPTG after a suitable OD 600 of 0.6-0.8 had been reached. For large-scale expression, four 50 ml SeMet medium pre-cultures supplemented with 100 mg ml À1 ampicillin, 0.2%(w/v) glucose and 50 mg ml À1 l-Met were started. After overnight incubation, the cells were pelleted and washed three times with 50 ml sterile water before being resuspended in 1 ml sterile water. A main culture of 4 l was then started by inoculating flasks containing 1 l pre-warmed (310 K) SeMet medium supplemented with 100 mg ml À1 ampicillin, 0.2%(w/v) glucose and 50 mg ml À1 l-SeMet with the 1 ml pre-cultures. Expression of the genes was induced by the addition of 1 mM IPTG after a suitable OD 600 of 0.6-0.8 had been reached. Cultures were grown overnight at 310 K with aeration and were harvested by centrifugation for 20 min [6500g (5000 rev min À1 in a JLA-8.1000 rotor), 277 K]. The bacterial pellets were resuspended in lysis buffer (50 mM Tris pH 8.0, 500 mM NaCl, 0.1 mg ml À1 AEBSF, 1 mg ml À1 leupeptin, 1 mM EDTA) and aliquoted in volumes of 50 ml. The aliquots were cryo-quenched using liquid nitrogen and stored at 192 K. The SeMet derivative of the full-length ParE2-PaaA2 complex was purified as described by Sterckx et al. (2012) . The identities of SeMet-derivatized PaaA2 and ParE2 were confirmed by N-terminal sequencing (Alta Biosciences).
Crystallization
Protein samples were dialyzed against a suitable buffer (20 mM Tris-HCl pH 8.0, 100 mM NaCl) and concentrated to 5-20 mg ml À1 (Amicon Ultra UltraCel 3K). Crystallization conditions were screened manually using the hanging-drop vapour-diffusion method in 48-well plates (Hampton VDX greased) with drops consisting of 2 ml protein solution (between 7 and 10 mg ml À1 ) and 2 ml reservoir solution equilibrated against 125 ml reservoir solution. Commercial screens from Hampton Research (Crystal Screen, Crystal Screen 2, Natrix and Natrix 2), Molecular Dimensions (Morpheus, ProPlex 1 and ProPlex 2), and Jena Bioscience (JBScreen Classic 1-4) were used for initial screening. The FLAG and His tags were retained on the proteins for crystallization.
For the full-length ParE2-PaaA2 complex, crystals were obtained through variation of the precipitant concentration [4-16%(w/v) PEG 6000], protein concentration (5-15 mg ml À1 ) and pH (5.0-7.0) of a promising hit [Molecular Dimensions ProPlex 1 condition No. 41: 100 mM MgCl 2 , 100 mM MES pH 6.0, 8%(w/v) PEG 6000] in an attempt to further optimize this condition. The final crystallization condition differed by only 0.1 pH unit from the initial hit [100 mM MgCl 2 , 100 mM MES pH 6.1, 8%(w/v) PEG 6000] and yielded platelike crystals with a reasonable thickness. Diffraction-quality crystals typically grew after approximately 7 d at 293 K using protein concentrations between 7 and 11.5 mg ml À1 . Crystals of the SeMet derivative of the full-length ParE2-PaaA2 complex were obtained by micro-seeding with the native complex. Briefly, native crystals were transferred to 50 ml mother liquor [100 mM MgCl 2 , 100 mM MES pH 6.1, 8%(w/v) PEG 6000] and vortexed (15 s) to obtain microseeds, which were used immediately. Serial dilutions of the seeds ranging from 1 to 10 À7 were mixed in a 1:1 ratio (2 ml each) with fresh SeMetderivatized protein solution at 10 mg ml À1 and equilibrated against the mother liquor. Diffraction-quality crystals typically grew after approximately 7 d at 293 K.
For ParE2-PaaA2 13-63 , a single large crystal of up to 300 mm in length grew in Molecular Dimensions ProPlex 2 condition No. 20 (100 mM sodium acetate pH 5.0, 1 M ammonium sulfate) about a month after the screen had been set up. The protein concentration used was 11.5 mg ml À1 and the crystal plate was incubated at 293 K.
Data collection and processing
All data sets were collected on the PROXIMA1 beamline at the SOLEIL synchrotron (Gif-Sur-Yvette, France) and were processed with XDS (Kabsch, 2010) . The quality of the collected data sets was verified by close inspection of the XDS output files and through phenix.xtriage (Zwart et al., 2005) in the PHENIX package (Adams et al., 2010) . Twinning tests were also performed by phenix.xtriage. Analysis of the unit-cell contents was performed with the program MATTHEWS_COEF, which is part of the CCP4 package (Winn et al., 2011) .
Crystals of the SeMet derivative of the full-length ParE2-PaaA2 complex were cryo-quenched in liquid nitrogen with the addition of 15%(v/v) glycerol to the mother liquor as a cryoprotectant. For the final data collection, 400 of data were collected from a single SeMetderivative crystal in 0.1 slices using a PILATUS 6M detector with an exposure time of 0.1 s deg À1 , a crystal-to-detector distance of 600.8 mm and a wavelength of 0.97911 Å .
The single ParE2-PaaA2 13-63 crystal was cryo-quenched in liquid nitrogen with the addition of 15%(v/v) glycerol to the mother liquor as a cryoprotectant. For the final data collection, 200 of data were collected from a single crystal in 0.2 slices using a PILATUS 6M detector with an exposure time of 0.4 s deg À1 , a crystal-to-detector distance of 577.45 mm and a wavelength of 0.97911 Å .
Hydrodynamic characterization
Analytical gel-filtration experiments were performed on an Ä KTAexplorer platform (GE Healthcare) using a Superdex 75 HR 10/30 column (GE Healthcare) to determine the size and molecular mass of the purified ParE2-PaaA2 13-63 complex. The column was preequilibrated using running buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl) for at least one column volume. A 500 ml sample at a concentration of 2 mg ml À1 was injected using running buffer with a flow rate of 0.5 ml min À1 . To determine the molecular masses and the hydrodynamic radii of the proteins (Uversky, 1993) , the column was calibrated using molecular-mass standards from Bio-Rad.
Dynamic light-scattering (DLS) experiments were performed on a DynaPro plate reader (Wyatt Technology) in 50 mM Tris-HCl pH 8.0, 500 mM NaCl at room temperature (293 K). Data were measured for PaaA2 13-63 -ParE2 samples at different concentrations (1-10 mg ml À1 ).
Small-angle X-ray scattering (SAXS) studies were conducted on the SWING beamline at the SOLEIL synchrotron, Gif-sur-Yvette, France in HPLC mode (David & Pé rez, 2009) . A total volume of 80 ml ParE2-PaaA2 13-63 sample at 12 mg ml À1 was injected onto a KW402.5-4F column (Shodex) which had been pre-equilibrated with running buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl) for at least one column volume. The flow rate was set to 0.25 ml min À1 and data were collected with an exposure time of 0.75 s and a dead time of 1.5 s. Buffer data were collected at the beginning of the chromatogram and sample data were collected in the peak area. Data processing and analysis was performed with the programs provided in the ATSAS package (Petoukhov et al., 2012) , the online SAXSMoW application (Fischer et al., 2010) and the Q R method (Rambo & Tainer, 2013) .
Results and discussion
The crystallization of the full-length ParE2-PaaA2 toxin-antitoxin complex in space group P3 1 21 (or P3 2 21) has been described previously (Sterckx et al., 2012) . While crystals of the native complex could be obtained, they only diffracted to 3.8 Å resolution at best. In the absence of a suitable model for molecular replacement, efforts were directed towards obtaining heavy-atom and/or SeMet derivatives. Unfortunately, these attempts failed as the incorporation of heavy atoms reduced the diffraction power of the derivative crystals to a resolution of 8 Å in the best case. Further screening of crystallization conditions was pursued to find other diffraction-quality crystal forms. A promising hit was obtained from Molecular Dimensions ProPlex 1 condition No. 41 [100 mM MgCl 2 , 100 mM MES pH 6.0, 8%(w/v) PEG 6000]. As can be seen from Fig. 2(a) , the drop contains micro-crystals, which are unsuitable for diffraction experiments. Optimization of this initial hit led to a final crystallization condition [100 mM MgCl 2 , 100 mM MES pH 6.1, 8%(w/v) PEG 6000] which differed by only 0.1 pH unit from the initial hit and yielded plate-like crystals with a reasonable thickness (Fig. 2b) . Crystallization of the SeMet derivative of the ParE2-PaaA2 complex in this crystal form initially failed. SeMet-derivatized crystals could only be obtained through micro-seeding with seeds of the native crystals. Suitably sized SeMet-derivative crystals were produced by using a tenfold dilution of the native crystal seeds and incubating the drops at 293 K (Fig. 2c ). Prior to data collection, the SeMet-derivatized crystals were cryo-quenched in liquid nitrogen with an additional cryoprotectant in two different cryosolutions, either by increasing the PEG 6000 concentration to 30%(w/v) or by the addition of 15%(v/v) glycerol to the mother liquor. The presence of selenium in the cryo-quenched protein crystals was confirmed at the beamline by an X-ray fluorescence scan (Fig. 3) . Interestingly, the crystals cryo-quenched in the first cryosolution had no diffraction power at all, while the crystals cryo-quenched in the cryosolution containing 15%(v/v) glycerol typically diffracted to a resolution of 2.8 Å (Fig. 4a ). The crystals belonged to space group P4 1 2 1 2 (or P4 3 2 1 2), with unit-cell parameters a = b = 90.5, c = 412.3 Å (Table 1) . This unit cell is consistent with a large oligomeric species as in the case of the P3 1 21 (or P3 2 21) crystal form of the ParE2-PaaA2 toxinantitoxin complex described previously (Sterckx et al., 2012) . Data were also collected from the native crystals, which had the same diffraction quality. However, as will be discussed below, the single data set collected from the SeMet-derivatized crystals should prove sufficient to allow structure determination.
Recently, it was suggested that the first 12 N-terminal residues of PaaA2 could be important for oligomerization of the ParE2-PaaA2 toxin-antitoxin complex. Furthermore, based on sequence comparisons within the RelB antitoxin superfamily and the solution structure of the PaaA2 antitoxin, it was envisaged that these residues would not be crucial for toxin inhibition in vivo (Sterckx et al., 2014) . Indeed, the crystallization communications
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Figure 3
An X-ray fluorescence scan (relative units) of a crystal of an SeMet derivative of the full-length ParE2-PaaA2 complex displays an absorption peak close to 12.66 keV, which is typical for SeMet. Figure 4 (a) Diffraction pattern of an SeMet-derivatized crystal similar in size to that shown in Fig. 1(c) . It shows diffraction spots to 2.8 Å resolution (the 2.8 Å resolution limit is indicated by an orange circle). (b) Diffraction pattern of the only crystal of the ParE2-PaaA2 13-63 complex. The crystal shows diffraction spots to 2.7 Å resolution (the 2.7 Å resolution limit is indicated by an orange circle). paaA2 13-63 and parE2 genes can be easily co-expressed in E. coli BL21 (DE3) cells without any toxicity effects on the bacterial culture. Assuming equimolar production of proteins (" 280 nm = 1.34 mg À1 ml cm À1 for a ParE2-PaaA2 13-63 heterodimer), about 20 mg protein is produced per litre of culture after overnight induction. During IMAC, a single peak containing both proteins elutes at 0.15 M imidazole. A subsequent gel-filtration step to polish the protein preparation reveals that PaaA2 13-63 and ParE2 co-elute in a single peak, suggesting the existence of a ParE2-PaaA2 13-63 toxinantitoxin complex. To characterize its hydrodynamic behaviour and its oligomerization state in solution, a combination of analytical gel filtration, DLS and SAXS was employed. As can be seen from Figs. 5(a) and 5(b), analytical gel-filtration and DLS experiments reveal that the ParE2-PaaA2 13-63 complex has hydrodynamic properties corresponding to those expected for a heterodimer (theoretical molecular mass of 18.92 kDa). The higher values for the molecular mass and hydrodynamic radius obtained via DLS compared with those from analytical gel filtration are most probably a consequence of the long N-terminal His tag on the toxin (see Fig. 1 ). The heterodimeric state of the ParE2-PaaA2 13-63 complex is confirmed by the results of the SAXS analysis ( Figs. 5c-5e ), which show that the scattering particle is small (R g = 21.70 Å ; D max = 75.54 Å ) and has an estimated molecular mass of around 20 kDa (21.10 kDa as estimated by SAXSMoW and 18.62 kDa by the Q R method), which matches the expected molecular mass very well. Although the complex behaves as a globular entity in solution, the normalized Kratky plot suggests the presence of flexibility in the scattering particle (Fig. 5d ), which can again be accounted for by the flexibility of the long N-terminal His tag on the toxin.
In order to obtain diffraction-quality crystals of the ParE2-PaaA2 13-63 complex, many different conditions were screened (variation in protein concentration, temperature and crystallization screens and optimization of the conditions thereof). However, none of them seemed to produce promising hits. About a month after the The ParE2-PaaA2 13-63 complex exists as a heterodimer in solution. (a) Analytical gel filtration. The experiment was performed on a Superdex 75 HR 10/30 column. The black and grey traces indicate the elution profiles for the ParE2-PaaA2 13-63 complex and the Bio-Rad standard (A, bovine thyroglobulin, molecular mass 670 kDa, R h = 8.6 nm; B, bovine -globulin, molecular mass 158 kDa, R h = 5.1 nm; C, chicken ovalbumin, molecular mass 44 kDa, R h = 2.8 nm; D, horse myoglobin, molecular mass 17 kDa, R h = 1.9 nm; E, vitamin B 12 , molecular mass 1.35 kDa), respectively. The inset shows an SDS-PAGE analysis of the elution peak. PaaA2 13-63 and ParE2 are indicated by blue and red arrows, respectively. Lane M, Prestained Protein Molecular Weight Marker (Fermentas); lanes 1-3, fractions of the ParE2-PaaA2 13-63 complex elution peak. (b) DLS. The black dots and grey line represent the experimental data and the fit, respectively. The residuals are shown below. The percentage of mass as a function of the R h distribution is given in the inset. (c) The final scattering curve of the ParE2-PaaA2 13-63 complex. The experimental data are shown in black, while the error margins are shown in grey. The inset shows the Guinier region of the scattering curve (experimental data in black and the Guinier fit in grey). (d) The normalized Kratky plot of the recorded data set indicates the presence of flexibility in the scattering particle. (e) An analysis of the p(r) function demonstrates that the scattering particle has a maximum intra-particle distance of around 75 Å . initial screen had been set up, a single large crystal of up to 300 mm in length grew in 100 mM sodium acetate pH 5.0, 1 M ammonium sulfate (Molecular Dimensions ProPlex 2 condition No. 20). The single ParE2-PaaA2 13-63 crystal was cryo-quenched in liquid nitrogen with the addition of 15%(v/v) glycerol to the mother liquor as a cryoprotectant. The crystal diffracted to a resolution of $ 2.7 Å . The diffraction pattern displays ice rings at 3.65 Å and reveals the presence of multiple lattices (Fig. 4b) . Nonetheless, the most prominent lattice could be successfully indexed and integrated. The crystal belonged to space group P6 1 22 (or P6 5 22), with unit-cell parameters a = b = 91.6, c = 185.6 Å (data-collection statistics are given in Table 1 and the Matthews analysis in Table 2 ).
Structure determination of the ParE2-PaaA2 toxin-antitoxin complex via single-wavelength anomalous diffraction (SAD) appears encouraging. The R anom /R p.i.m. ratio exceeds 1.5 (R anom /R p.i.m. = 1.73), which indicates that structure determination is likely to succeed (Weiss, 2001) . In turn, structure determination of the ParE2-PaaA2 toxin-antitoxin complex in the P4 1 2 1 2 (or P4 3 2 1 2) crystal form will lead towards obtaining the crystal structures of the ParE2-PaaA2 complex in the P3 1 21 (or P3 2 21) crystal form and the ParE2-PaaA2 13-63 heterodimer via molecular replacement. Combined with solution studies on the full-length ParE2-PaaA2 toxin-antitoxin complex (Sterckx et al., 2012) , this will finally shed light on the exact stoichiometry and architecture of this unusually large toxin-antitoxin oligomer, the biological function of which still remains elusive. Interestingly, our solution studies on the ParE2-PaaA2 13-63 complex suggest that the first 12 N-terminal residues of PaaA2 play an important role in the assembly of the ParE2-PaaA2 oligomer. Based on the differences between the constructs used to produce the ParE2-PaaA2 and ParE2-PaaA2 13-63 complexes, it seems that the displacement of the His tag on the toxin from the C-terminus to the N-terminus and/or the removal of the first 12 N-terminal residues from the antitoxin prevents the formation of a higher-order ParE2-PaaA2 oligomer. It is expected that a comparison between the crystal structures of the ParE2-PaaA2 and ParE2-PaaA2 13-63 complexes will yield insights into the molecular driving forces behind the assembly (and disassembly) of the large ParE2-PaaA2 toxin-antitoxin oligomer. Table 2 Matthews analysis.
The analysis was conducted using the molecular mass of a ParE2-PaaA2 heterodimer (theoretical molecular mass 20.184 kDa) or a ParE2-PaaA2 13-63 heterodimer (theoretical molecular mass 18.924 kDa). In both cases a 1:1 stoichiometry was assumed. AU and V M are the asymmetric unit and the Matthews coefficient, respectively. 
